Innate immunity in amyotrophic lateral sclerosis.

Area of Science:

• Neuroscience
• Immunology
• Neurodegenerative Diseases

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease targeting motor neurons.
• Neuroinflammation is observed in ALS patients and animal models, suggesting a role for innate immunity.
• The precise role of innate immunity in ALS pathogenesis is complex, with potential for both harm and benefit.

Purpose of the Study:

• To explore the role of innate immunity and neuroinflammation in ALS pathogenesis.
• To investigate the therapeutic potential of modulating microglial function in ALS.
• To understand the ambivalent effects of innate immune effectors in the central nervous system (CNS) in ALS.

Main Methods:

• Review of evidence implicating innate immunity in ALS.
• Analysis of studies involving attenuation of inflammatory responses in ALS models.
• Examination of research on sensitizing and modulating innate immune cells in ALS.

Main Results:

• Neuroinflammation is a consistent feature in ALS, correlating with motor neuron loss.
• Interventions targeting inflammation and innate immunity have shown efficacy in ALS models.
• Innate immune effectors in the CNS exhibit dual roles, potentially promoting repair or injury.

Conclusions:

• Modulating microglial function represents a significant therapeutic avenue for ALS.
• Understanding the complex role of innate immunity is crucial for developing effective ALS treatments.
• Targeting neuroinflammation may offer insights into the selective vulnerability of motor neurons in ALS.